Experimental studies indicate that IL-33 can reduce atherosclerosis development in ApoE-/- mice on a high-fat diet by increasing serum levels of IL-5 and the production of antioxidized low-density lipoprotein antibodies, while mice treated with sST2 develop significantly larger atherosclerotic plaques [98]. Here, IL33 is linked to atherosclerosis.